The AMA CPT Editorial Panel established CPT code 0991T effective January 1, 2026
GLP-1 Agonists Pipeline Development Activities The GLP-1 agonists therapeutics market report covers information on collaborations, acquisitions and mergers, licensing, and patent details for Glucagon-like Peptide-1 (GLP-1) Agonists
Novo Nordisks semaglutide, marketed as Wegovy for people with obesity and Ozempic for those with Type 2 diabetes, has been on the FDA Drug Shortages list since August 2022
We work with OB/GYN specialists to provide safe care plans based on proven methods
This therapy is about supporting your body's natural processes, so the results build gradually over time
Cosmetics need to be tried to make sure they are safe for use so that skin doesn't get itchy, photosensitive, or unstable